<DOC>
	<DOCNO>NCT02114047</DOCNO>
	<brief_summary>This study evaluate blood flow lung patient prior surgery treatment .</brief_summary>
	<brief_title>Pulmonary Perfusion Heterogeneity Patients With CTEPH Using Functional PET Imaging</brief_title>
	<detailed_description>Specifically , evaluate length-scale size blood flow alteration use filter technique objective identify size blood vessel obstruct clot ( large vessel versus small vessel ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>1 . Subject diagnose chronic thromboembolic pulmonary hypertension ( WHO Group IV ) plan undergo pulmonary thromboendarterectomy . 2 . Subject male female age &gt; =18 year age &lt; = 70 year . 3 . Subject undergone RHC within six month enter study . 4 . The subject capable give informed consent , include compliance requirement restriction list consent form . 5 . A signed date write informed consent obtain subject . 6 . Available complete study . 7 . Able lie flat able perform 30 second breath hold . 1 . FEV1 and/or TLC &lt; 70 % predict . 2 . Inability perform study ( primary MD investigator assessment ) . 3 . Inability perform respiratory maneuver necessary exam . 4 . Subjects past present disease , judge Investigators may affect outcome study . 5 . The subject suspect history drug alcohol abuse within six month prior screen visit . 6 . The subject woman childbearing potential pregnant , seek become pregnant , positive pregnancy test . 7 . Subject clinical instability judgment investigator , heart rate &gt; 120 bpm , respiratory rate &gt; 24 , SpO2 &lt; 88 % , blood pressure &lt; 90/60 &gt; 140/90 fever &gt; 101 , subject hospitalization progression pulmonary hypertension right heart failure three month prior study . 8 . Subject diagnosis active tuberculosis , lung cancer , clinically overt bronchiectasis , allergic rhinitis , asthma , heart failure , ischemic heart disease , COPD . 9 . Subject respiratory tract infection 4 week prior screen visit throughout duration study . 10 . The subject expose radiation dose past year , add radiation dose expect study , would exceed permissible yearly exposure determine MGH radiation safety committee .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>